Research Progress in Clinical Treatment of Polycystic Ovary Syndrome from the Perspective of Evidence-Based Medicine: A Comprehensive Evaluation of Hormonal Therapy and Traditional Chinese Medicine Regimens

Zhao Wang, Nan Li

Show Less

¹ Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China,

AOGR 2026 , 4(2), 77–84; https://doi.org/10.26689/aogr.v4i2.15114

© 2026 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that significantly impairs female fertility and overall health. With the advancement of evidence-based medicine, therapeutic approaches for PCOS have become increasingly diversified. As two major treatment modalities, hormonal therapy and traditional Chinese medicine (TCM) have attracted widespread attention. Although numerous studies have explored the efficacy and safety of different treatment regimens, many controversies and deficiencies still exist in clinical practice. From the perspective of evidence-based medicine, this review systematically assesses the clinical application effects of hormonal therapy and TCM for PCOS. Through a comprehensive analysis of relevant literature, it compares the efficacy of various treatments and puts forward evidence-based therapeutic recommendations. This study aims to provide a scientific reference for clinical decision-making and promote the progress of comprehensive management and treatment of PCOS.

References

Peker N, Turan G, Ege S, et al., 2021, The Effect of Clomiphene Citrate on Oxidative Stress Parameters in Polycystic Ovarian Syndrome. J Obstet Gynaecol, 41(1): 112–117.

Achu JR, Ajitkumar S, Kanakasabapathy BS, et al., 2023, Evaluation of Microbial Profile in Patients with Polycystic Ovary Syndrome and Periodontal Disease: A Case-Control Study. Int J Fertil Steril, 17(4): 248–253.

Stener-Victorin E, Teede H, Norman RJ, et al., 2024, Polycystic Ovary Syndrome. Nat Rev Dis Primers, 10(1): 27.

Benham JL, Goldberg A, Teede H, et al., 2024, Polycystic Ovary Syndrome: Associations with Cardiovascular Disease. Climacteric, 27(1): 47–52.

Wang Y, Guo L, Jiang J, et al., 2021, Development of 1–2 Years Offspring Born to Mothers with Polycystic Ovary Syndrome. J Coll Physicians Surg Pak, 31(10): 1186–1190.

Shinoda M, Hayashi Y, Kubo A, et al., 2020, Pathophysiological Mechanisms of Persistent Orofacial Pain. J Oral Sci, 62(2): 131–135.

Polak G, Banaszewska B, Filip M, et al., 2021, Environmental Factors and Endometriosis. Int J Environ Res Public Health, 18(21): 11025.

Khalaf S, Al Anzy M, Sarhat E, 2024, Impact of Metformin on Osteoprotegerin Levels in Polycystic Ovarian Women. Georgian Med News, (346): 144–146.

Rankin KA, Mei F, Kim K, et al., 2019, Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors. J Neurosci, 39(12): 2184–2194.

Goldstein SR, 2022, Selective Estrogen Receptor Modulators and Bone Health. Climacteric, 25(1): 56–59.

Paton DM, 2022, Estetrol and Drospirenone: A Novel Oral Contraceptive. Drugs Today (Barc), 58(1): 1–8.

Mierzejewska A, Walędziak M, Merks P, et al., 2024, Emergency Contraception – A Narrative Review of Literature. Eur J Obstet Gynecol Reprod Biol, 299: 188–192.

Amisi CA, 2022, Markers of Insulin Resistance in Polycystic Ovary Syndrome Women: An Update. World J Diabetes, 13(3): 129–149.

Yu H, Sun J, Hu H, 2024, Prophylactic Administration of Metformin Reduces Gestational Diabetes Mellitus Incidence in the High-Risk Populations: A Meta-Analysis of Metformin for Gestational Diabetes Prevention. Ir J Med Sci, 193(1): 199–209.

Dinicola S, Unfer V, Soulage CO, et al., 2024, d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI). Gynecol Obstet Invest, 89(4): 284–294.

Guarano A, Capozzi A, Cristodoro M, et al., 2023, Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth? Nutrients, 15(14): 3209.

Chen H, Deng C, Meng Z, et al., 2023, Effects of TCM on Polycystic Ovary Syndrome and Its Cellular Endocrine Mechanism. Front Endocrinol (Lausanne), 14: 956772.

Zhang Y, Guo X, Ma S, et al., 2021, The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome. Evid Based Complement Alternat Med, 2021: 6678398.

Fu LW, Gao Z, Zhang N, et al., 2024, Traditional Chinese Medicine Formulae: A Complementary Method for the Treatment of Polycystic Ovary Syndrome. J Ethnopharmacol, 323: 117698.

Yang Y, Xia Y, Peng X, et al., 2021, Tanshinone for Polycystic Ovary Syndrome: A Protocol of Systematic Review and Meta-Analysis. Medicine (Baltimore), 100(3): e24287.

Chen Y, Chai X, Zhao Y, et al., 2021, Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach. Evid Based Complement Alternat Med, 2021: 6843828.

Cao Y, Chen H, Zhao D, et al., 2019, The Efficacy of Tung’s Acupuncture for Sex Hormones in Polycystic Ovary Syndrome: A Randomized Controlled Trial. Complement Ther Med, 44: 182–188.

Li H, Li Y, Zhang Y, et al., 2023, Rubus chingii Hu Relieved the Polycystic Ovary Syndrome with Enhanced Insulin Sensitivity Through Inhibiting TXNIP/NLRP3 Inflammasome Signaling. Gynecol Endocrinol, 39(1): 2237116.

Lu LJ, Zhang J, Jiang Y, et al., 2024. Zhongguo Zhong Yao Za Zhi, 49(1): 1–14.

Sun L, Yin B, Yao Z, et al., 2024, Comparison of Clinical Outcomes and Perinatal Outcomes Between Natural Cycle and Hormone Replacement Therapy of Frozen-Thawed Embryo Transfer in Patients with Regular Menstruation: A Propensity Score-Matched Analysis. Front Endocrinol (Lausanne), 15: 1416841.

Liu L, Liu Y, Yang M, et al., 2020, Effectiveness of Tonifying-Kidney and Regulating-Liver Therapy on Diminished Ovarian Reserve: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Tradit Chin Med, 40(3): 343–354.

Hu J, Shi W, Xu J, et al., 2021, Complementary and Alternative Medicine for the Treatment of Abnormal Endometrial Conditions in Women with PCOS: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med, 2021: 5536849.

Lethaby A, Wise MR, Weterings MA, et al., 2019, Combined Hormonal Contraceptives for Heavy Menstrual Bleeding. Cochrane Database Syst Rev, 2(2): CD000154.

Orsolini L, Pompili S, Volpe U, 2020, The ‘Collateral Side’ of Mood Stabilizers: Safety and Evidence-Based Strategies for Managing Side Effects. Expert Opin Drug Saf, 19(11): 1461–1495.

Meng Z, Chen H, Deng C, et al., 2022, Potential Cellular Endocrinology Mechanisms Underlying the Effects of Chinese Herbal Medicine Therapy on Asthma. Front Endocrinol (Lausanne), 13: 916328.

Wang LL, Xiang YG, Tan L, et al., 2021. Zhongguo Zhen Jiu, 41(7): 742–746.

Mohamad T, Jyotsna F, Farooq U, et al., 2023, Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors. Cureus, 15(8): e43977.

Cocchetti C, Ristori J, Romani A, et al., 2020, Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. J Clin Med, 9(6): 1609.

Horlait M, Baes S, De Regge M, et al., 2021, Understanding the Complexity, Underlying Processes, and Influencing Factors for Optimal Multidisciplinary Teamwork in Hospital-Based Cancer Teams: A Systematic Integrative Review. Cancer Nurs, 44(6): E476–E492.

Previous article in this issue

Next article in this issue